People · Operator
Named in public records as an officer, director or promoter · active 2014–2024 · Biotechnology, Healthtech, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Delphinus Medical Technologies, Inc. | — | Biotechnology | Series B | $117.9M | $221.7M | 2017 |
| Health Scholars, Inc. | — | Healthtech | Series A | $13.3M | $89.8M | 2019 |
| Great Lakes Pharmaceuticals, Inc. | — | Pharmaceuticals | Series A | $11.2M | $347.5M | 2014 |
John Neis at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Neis on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Fulton | 2 | 2 |
| Scott Johnson | 1 | 10 |
| Michael Gross | 1 | 9 |
| Scott White | 1 | 7 |
| Paul McCreadie | 1 | 6 |
| Alvin Vitangcol | 1 | 5 |
| Fred Schwarzer | 1 | 4 |
| Gino DiSciullo | 1 | 4 |
| Gary Durack | 1 | 4 |
| Thomas Shehab | 1 | 4 |
| Kristen Valdes | 1 | 3 |
| Rikard Steiber | 1 | 2 |
| Michael J. Gross | 1 | 2 |
| Paul J. McCreadie | 1 | 2 |
| Jeff Stein | 1 | 2 |
| Rachel Brem | 1 | 2 |
| Michael J. Fulton | 1 | 2 |
| Angela McFarland | 1 | 2 |
| Mark J. Forchette | 1 | 2 |
| LAURA MEDINA | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.